已收录 268921 条政策
 政策提纲
  • 暂无提纲
Menstrual tampons and vaginal pessaries: regulation of intravaginal medical devices by the US FDA
[摘要] Catamenial products like menstrual tampons for managing menses and vaginal pessaries for managing urinary incontinence and uterine prolapse are products that can be inserted and removed from the vagina repeatedly over a woman's lifetime. In the United States (US), these products are considered to be medical devices and are regulated by the Center for Devices & Radiological Health (CDRH) of the Food and Drug Administration (FDA). As such, they are subject to both premarket and postmarket regulatory controls. Both tampons and pessaries have a long history of safe and effective use, and FDA applies a risk-based approach to both premarket entry as well as continued postmarket regulatory controls. Practicing clinicians are often the initial source of ideas for medical device improvements. This article is intended to help such clinicians to understand the regulatory challenges faced by development teams who seek to introduce these kinds of products to the US market. It explains FDA's risk-based classification of medical devices and the 510(k) premarket notification as the primary regulatory mechanism for market entry. It also highlights key FDA guidance documents and encourages early engagement with FDA when appropriate.
[发布日期] 2023-09-19 [发布机构] 
[效力级别]  [学科分类] 
[关键词] menstrual tampons;vaginal pessaries;medical device;regulation;food and drug administration;510(k) premarket notification [时效性] 
   浏览次数:2      统一登录查看全文      激活码登录查看全文